Korro Bio is Drug Discovery in United States that focus on developer business. Founded in 2018. They cover business area such as developer, transformative RNA therapeutic, patient, rare and debilitate disease, transformative treatment, nucleic acid-base therapeutic, responsible sequence, healthcare provider, rare genetic disease.
2018
( 6 years old in 2024 )
Developer
-
One Kendall Square
Building 600-700, Suite 6-401
Cambridge, MA 02139
United States
Private
developertransformative RNA therapeuticpatientrare and debilitate diseasetransformative treatmentnucleic acid-base therapeuticresponsible sequencehealthcare providerrare genetic disease
* We use standard office opening hours in near Korro Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Korro Bio is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Korro Bio business is focusing on Developer.
Korro Bio headquarter office and corporate office address is located in One Kendall Square Building 600-700, Suite 6-401 Cambridge, MA 02139 United States.
Korro Bio was founded in United States.
In 2024, Korro Bio is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Korro Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
